Brett Abrahams - drug development and neurogenomics episode artwork

EPISODE · Apr 20, 2021 · 39 MIN

Brett Abrahams - drug development and neurogenomics

from The Bioinformatics CRO Podcast

Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics. https://www.bioinformaticscro.com/

NOW PLAYING

Brett Abrahams - drug development and neurogenomics

0:00 39:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bioinformatics CRO Podcast?

This episode is 39 minutes long.

When was this The Bioinformatics CRO Podcast episode published?

This episode was published on April 20, 2021.

What is this episode about?

Brett Abrahams, Executive VP of R&D at Magnolia Neurosciences, discusses his work on chemotherapy-induced peripheral neuropathy and other brain disorders. The Bioinformatics CRO is a fully distributed contract research company that serves the...

Can I download this The Bioinformatics CRO Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!